Diabetes: Impact on Stroke Risk and Poststroke Recovery

Brett Kissela; Ellen Air

doi:10.1055/s-2006-933313

Seminars in Neurology, Table of Contents

Semin Neurol 2006; 26(1): 100-107
DOI: 10.1055/s-2006-933313

Diabetes: Impact on Stroke Risk and Poststroke Recovery

Brett Kissela¹ , Ellen Air²

¹Department of Neurology, University of Cincinnati, Cincinnati, Ohio
²Department of Neurosurgery, University of Cincinnati, Cincinnati, Ohio

Abstract

ABSTRACT

The prevalence of diabetes has been increasing substantially each year. Thus, diabetes has become one of the most important risk factors for incident and recurrent ischemic strokes. The risk conferred by diabetes is higher for diabetic patients who are less than age 65 and is proportionally higher in race-ethnic minorities where diabetes prevalence is higher than for Caucasians. To reduce risk of ischemic stroke, a structured program that addresses all of the diabetes-associated risk factors of the metabolic syndrome is likely to be most effective. Diabetes increases poststroke mortality and adversely affects poststroke outcomes as compared with stroke patients without diabetes. Further research is needed to clarify optimal ways of reducing mortality and improving outcomes.

KEYWORDS

Ischemic stroke - diabetes - insulin resistance

Full Text

References

REFERENCES

1 American Heart Association .Heart Disease and Stroke Statistics: 2005 Update. Dallas, TX; American Heart Association, Inc. 2005
2 Goldstein L B, Adams R, Becker K et al.. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001; 32 280-299
3 CDC/National Center for Health Statistics .Available at: http://www.cdc.gov/nchs/fastats/diabetes.htm Accessed March 2005
4 CDC/National Center for Health Statistics. Leading causes of death .http://Available at: www.cdc.gov/nchs/deaths.htm Accessed December 2005
5 Mokdad A H, Ford E S, Bowman B A et al.. Prevalence of obesity, diabetes, and obesity related health risk factors, 2001. JAMA. 2003; 289 76-79
6 Harris M I, Flegal K M, Cowie C C et al.. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994 [see comments]. Diabetes Care. 1998; 21 518-524
7 Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27 1047-1053
8 Koskinen S V, Reunanen A R, Martelin T P, Valkonen T. Mortality in a large population based cohort of patients with drug- treated diabetes mellitus. Am J Public Health. 1998; 88 765-770
9 Kissela B M, Khoury J, Kleindorfer D et al.. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care. 2005; 28 355-359
10 American Diabetes Association .The Diabetes-Heart Disease Link: Surveying Attitudes, Knowledge and Risk. Alexandria, VA; American Diabetes Association, American Academy of Cardiology 2003: 1-4
11 American Diabetes Association. Heart disease and stroke .http://Available at: www.diabetes.org/heart-disease-stroke.jsp Accessed March 2005
12 Bonora E, Willeit J, Kiechl S et al.. U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population: the Bruneck Study. Diabetes Care. 1998; 21 221-230
13 Lakka H M, Lakka T A, Tuomilehto J, Sivenius J, Salonen J T. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med. 2000; 160 1160-1168
14 Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol. 2000; 20 538-544
15 Despres J P, Lamarche B, Mauriege P et al.. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996; 334 952-957
16 Wannamethee S G, Perry I J, Shaper A G. Nonfasting serum glucose and insulin concentrations and the risk of stroke [comment]. Stroke. 1999; 30 1780-1786
17 Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia and the risk of stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Stroke. 1998; 29 1860-1866
18 Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 1994; 25 1157-1164
19 Folsom A R, Rasmussen M L, Chambless L E et al.. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care. 1999; 22 1077-1083
20 Gertler M M, Leetma H E, Koutrouby R J, Johnson E D. The assessment of insulin, glucose and lipids in ischemic thrombotic cerebrovascular disease. Stroke. 1975; 6 77-84
21 Whisnant J. Modeling of risk factors for ischemic stroke: the Willis lecture. Stroke. 1997; 28 1840-1844
22 Sacco R L, Boden-Albala B, Abel G et al.. Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke. 2001; 32 1725-1731
23 Broderick J, Brott T, Kothari R et al.. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever total incidence rates of stroke among blacks. Stroke. 1998; 29 415-421
24 Kissela B, Schneider A, Kleindorfer D et al.. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2004; 35 426-431
25 Pancioli A M, Broderick J, Kothari R et al.. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA. 1998; 279 1288-1292
26 Petty G W, Brown Jr R D, Whisnant J P, Sicks J D, O'Fallon W M, Wiebers D O. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology. 1998; 50 208-216
27 Sacco R L, Foulkes M A, Mohr J P, Wolf P A, Hier D B, Price T R. Determinants of early recurrence of cerebral infarction: the Stroke Data Bank. Stroke. 1989; 20 983-989
28 Sacco R L, Shi T, Zamanillo M C, Kargman D E. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994; 44 626-634
29 Hier D B, Foulkes M A, Swiontoniowski M et al.. Stroke recurrence within 2 years after ischemic infarction. Stroke. 1991; 22 155-161
30 Jorgensen H S, Nakayama H, Reith J, Raaschou H O, Olsen T S. Stroke recurrence: predictors, severity, and prognosis: the Copenhagen Stroke Study. Neurology. 1997; 48 891-895
31 UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352 837-853
32 The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329 977-986
33 UK Prospective Diabetes Study Group . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998; 317 703-713
34 Chobanian A V, Bakris G L, Black H R et al.. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42 1206-1252
35 Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000; 342 145-153
36 Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000; 355 253-259
37 MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360 7-22
38 Collins R, Armitage J, Parish S, Sleight P, Peto R. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004; 363 757-767
39 Corvol J C, Bouzamondo A, Sirol M, Hulot J S, Sanchez P, Lechat P. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Arch Intern Med. 2003; 163 669-676
40 Statins after ischemic stroke and transient ischemic attack: an advisory statement from the Stroke Council, American Heart Association and American Stroke Association. Stroke. 2004; 35 1023
41 Amarenco P, Bogousslavsky J, Callahan A S et al.. Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis. 2003; 16 389-395
42 Gaede P, Vedel P, Larsen N, Jensen G V, Parving H H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348 383-393
43 Gray C S, French J M, Bates D, Cartlidge N E, Venables G S, James O F. Increasing age, diabetes mellitus and recovery from stroke. Postgrad Med J. 1989; 65 720-724
44 Olsson T, Viitanen M, Asplund K, Eriksson S, Hagg E. Prognosis after stroke in diabetic patients: a controlled prospective study. Diabetologia. 1990; 33 244-249
45 Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke: prospective study of the middle-aged Finnish population. Stroke. 1996; 27 210-215
46 Lai S M, Alter M, Friday G, Sobel E. Prognosis for survival after an initial stroke. Stroke. 1995; 26 2011-2015
47 Kissela B M, Khoury J, Alwell K et al.. Long term mortality after ischemic stroke: the effect of diabetes in the greater Cincinnati/Northern Kentucky stroke study [abstract]. Stroke. 2004; 35 315
48 Johnston K C, Connors Jr A F, Wagner D P, Knaus W A, Wang X, Haley Jr E C. A predictive risk model for outcomes of ischemic stroke. Stroke. 2000; 31 448-455
49 NINDS t-PA Stroke Study Group . Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997; 28 2119-2125
50 Bruno A, Biller J, Adams Jr H P et al.. Acute blood glucose level and outcome from ischemic stroke: Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999; 52 280-284
51 Topic E, Pavlicek I, Brinar V, Korsic M. Glycosylated haemoglobin in clarification of the origin of hyperglycaemia in acute cerebrovascular accident. Diabet Med. 1989; 6 12-15
52 Kwakkel G, Wagenaar R C, Kollen B J, Lankhorst G J. Predicting disability in stroke: a critical review of the literature. Age Ageing. 1996; 25 479-489
53 Clavier I, Hommel M, Besson G, Noelle B, Perret J E. Long-term prognosis of symptomatic lacunar infarcts: a hospital-based study. Stroke. 1994; 25 2005-2009
54 Kernan W N, Viscoli C M, Brass L M et al.. The stroke prognosis instrument II (SPI-II): a clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke. 2000; 31 456-462
55 Lefkovits J, Davis S M, Rossiter S C et al.. Acute stroke outcome: effects of stroke type and risk factors. Aust NZJ Med. 1992; 22 30-35
56 Lai S M, Studenski S, Duncan P W, Perera S. Persisting consequences of stroke measured by the stroke impact scale. Stroke. 2002; 33 1840-1844
57 Jorgensen H S, Reith J, Nakayama H, Kammersgaard L P, Raaschou H O, Olsen T S. What determines good recovery in patients with the most severe strokes? The Copenhagen Stroke Study. Stroke. 1999; 30 2008-2012
58 Kotila M, Waltimo O, Niemi M L, Laaksonen R, Lempinen M. The profile of recovery from stroke and factors influencing outcome. Stroke. 1984; 15 1039-1044
59 Henon H, Godefroy O, Leys D et al.. Early predictors of death and disability after acute cerebral ischemic event. Stroke. 1995; 26 392-398
60 Allen C M. Predicting the outcome of acute stroke: a prognostic score. J Neurol Neurosurg Psychiatry. 1984; 47 475-480
61 Counsell C, Dennis M, McDowall M, Warlow C. Predicting outcome after acute and subacute stroke: development and validation of new prognostic models. Stroke. 2002; 33 1041-1047
62 Hankey G J, Jamrozik K, Broadhurst R J, Forbes S, Anderson C S. Long-term disability after first-ever stroke and related prognostic factors in the Perth Community Stroke Study, 1989-1990. Stroke. 2002; 33 1034-1040
63 Toni D, Fiorelli M, Bastianello S et al.. Acute ischemic strokes improving during the first 48 hours of onset-predictability, outcome, and possible mechanisms: a comparison with early deteriorating strokes. Stroke. 1997; 28 10-14
64 Samuelsson M, Soderfeldt B, Olsson G B. Functional outcome in patients with lacunar infarction. Stroke. 1996; 27 842-846
65 Wade D T, Wood V A, Hewer R L. Recovery after stroke: the first 3 months. J Neurol Neurosurg Psychiatry. 1985; 48 7-13
66 Bonita R, Ford M A, Stewart A W. Predicting survival after stroke: a three-year follow-up. Stroke. 1988; 19 669-673

Brett KisselaM.D.

Department of Neurology, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267-0525